PBH
Price
$45.28
Change
+$0.51 (+1.14%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
2.22B
34 days until earnings call
Intraday BUY SELL Signals
VSDB
Price
$74.43
Change
-$0.03 (-0.04%)
Updated
Oct 2, 04:59 PM (EDT)
Net Assets
1.04B
Intraday BUY SELL Signals
Interact to see
Advertisement

PBH vs VSDB

PBH vs VSDB Comparison Chart in %
View a ticker or compare two or three
VS
PBH vs. VSDB commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a StrongBuy and VSDB is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PBH: Fundamental Ratings
PBH
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
74
PRICE GROWTH RATING
1..100
74
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PBHVSDB
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
15%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 3 days ago
6%
MACD
ODDS (%)
Bearish Trend 2 days ago
50%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
10%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
56%
N/A
Advances
ODDS (%)
Bullish Trend 5 days ago
53%
Bullish Trend 3 days ago
23%
Declines
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 9 days ago
7%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
20%
Aroon
ODDS (%)
Bearish Trend 2 days ago
54%
N/A
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (PBH: $44.77)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 0 FA rating(s) are green while .

  • PBH’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 4 TA indicator(s) are bullish.

  • PBH’s TA Score: 4 bullish, 6 bearish.

Price Growth

PBH (@Pharmaceuticals: Generic) experienced а -1.93% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.71%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +29.84%.

Reported Earning Dates

PBH is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.71% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
PBH
Daily Signal:
Gain/Loss:
VSDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MMYT47.750.55
+1.17%
MakeMyTrip Limited
VMRK60.17-0.59
-0.97%
Vivmark Residential
SBGI12.51-0.18
-1.42%
Sinclair
VTGN0.28-0.02
-8.19%
VistaGen Therapeutics
GDEV10.26-1.17
-10.24%
GDEV Inc

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with HLN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
-2.40%
HLN - PBH
36%
Loosely correlated
-3.11%
PRGO - PBH
34%
Loosely correlated
-5.01%
AMPH - PBH
32%
Poorly correlated
-1.78%
ANIP - PBH
31%
Poorly correlated
+0.43%
ELAN - PBH
29%
Poorly correlated
-2.77%
More

VSDB and

Correlation & Price change

A.I.dvisor tells us that VSDB and WS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VSDB and WS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSDB
1D Price
Change %
VSDB100%
-0.27%
WS - VSDB
27%
Poorly correlated
+3.12%
PBH - VSDB
11%
Poorly correlated
-2.40%